Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0025202 (
melanoma
)
69,561
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
B16
melanoma
sublines (B16-F10-BL6 and B16-F1) exhibited elevated adenosine 3',5'-cyclic monophosphate (cAMP) levels when cultured in Dulbecco's modified Eagle's medium (DMEM) in comparison to cells in RPMI-1640 medium. In parallel, cells cultured in DMEM had increased tyrosinase activity, melanization and dendrite formation, all markers of
melanoma
differentiation. Also, the proliferative rates of both cell lines were decreased by 80-85% when cultured in DMEM relative to cells maintained in RPMI-1640 medium. In these studies, elevated levels of the melanin precursors tyrosine (Tyr) and phenylalanine (Phe) found in DMEM were shown not to be solely responsible for the phenotypic changes observed with DMEM. Both BL6 and B16-F1 cell lines formed more experimental pulmonary tumor metastasis in syngeneic C57BL/6 mice when maintained in DMEM vs RPMI-1640 medium. Analysis of metastasis formation in nude mice with normal and depleted natural killer (NK) cell activity revealed that the enhanced lung colonizing capacity of the BL6 cells maintained in DMEM was independent of the function of T-cell or NK-cell-mediated immunity. A close association between metastatic ability of tested lines and the expression of the membrane-associated enzyme
gamma-glutamyltranspeptidase
(gamma-GTPase,
EC 2.3.2.2
) was observed. The highly metastatic BL6 cell line had 20-fold higher levels of gamma-GTPase activity than the weakly metastatic B16-F1 cell line. Both cell lines, when grown in DMEM, had elevated gamma-GTPase activity that paralleled augmentation of metastatic ability. The dramatic changes in lung-colonizing capacity of the variant B16
melanoma
cells maintained in DMEM in contrast to those grown in RPMI-1640 medium may serve as a useful model in understanding certain steps involved in triggering cell differentiation as well as metastasis development.
...
PMID:Enhancement of pulmonary metastasis formation and gamma-glutamyltranspeptidase activity in B16 melanoma induced by differentiation in vitro. 809 41
The effects of a series of D- and L-amino acid alcohols on the proliferation and phenotypic expression of B16 mouse
melanoma
cells were evaluated. B16
melanoma
cells were incubated for different time intervals in the presence of D- or L-phenylalaninol (PHE), D- or L-alaninol (AL), D- or L-leucinol (LE), L-histidinol (HIS), L-tyrosinol (TYR) and L-methioninol (MET). All agents, including the D or L configuration, induced an anti-proliferative effect, although of considerably different magnitude. D-PHE was the most active growth inhibitor. The growth inhibitory effects were accompanied by phenotypic alterations, which included morphological changes and enhancement in the activities of NADPH cytochrome c reductase and tau-
glutamyl transpeptidase
. These phenotypic alterations correlated with the growth inhibitory effects of the different agents and seem to reflect a higher differentiated state.
...
PMID:Amino acid alcohols: growth inhibition and induction of differentiated features in melanoma cells. 809 46
A proposed mechanism for the
melanoma
specific activity of phenolic amines is based upon the ability of the enzyme tyrosinase to oxidize these prodrugs to toxic intermediates. In this study, we synthesized an iodinated analog of gamma-L-glutaminyl-4-hydroxybenzene (GHB) with increased antimelanoma activity in both human and murine
melanoma
cell lines. GHB and gamma-L-glutaminyl-4-hydroxy-3-iodobenzene (I-GHB) were shown to be substrates for both mammalian and mushroom tyrosinase. Glutathione, a cellular antioxidant, inhibited tyrosinase mediated formation of gamma-L-glutaminyl-3,4-benzoquinone (GBQ) from GHB, inhibited melanin production, and blocked the inhibition of the enzyme thymidylate synthase by oxidized GHB. Buthionine sulfoximine (BSO) depletion of cellular glutathione enhanced the growth inhibitory activity and the inhibition of in situ thymidylate synthase by phenolic amines in
melanoma
cells. GHB and I-GHB were shown to be approximately 5- and 10-fold more cytotoxic, respectively, in highly metastatic B16-BL6 cells than in weakly metastatic B16-F1 cells with approximately equal tyrosinase activity. B16-BL6 cells had approximately 20-fold higher
gamma-glutamyltranspeptidase
(gamma-GTPase) activity than B16-F1 cells which suggested the possible involvement of this enzyme in the activation of the cytotoxicity of the phenolic amines. 4-Aminophenol, a product of gamma-GTPase reaction with GHB, was a substrate for tyrosinase and a potent inhibitor of in situ thymidylate synthase activity in melanogenic cells. In pigmented
melanoma
cells containing the enzyme tyrosinase, the quinone mediated mechanism of phenolic amine cytotoxicity may be uniquely important and the cellular antioxidant glutathione essential in the detoxification of these quinone-generated intermediates.
...
PMID:Mechanism(s) regulating inhibition of thymidylate synthase and growth by gamma-L-glutaminyl-4-hydroxy-3-iodobenzene, a novel melanin precursor, in melanogenic melanoma cells. 843 97
The cellular concentration of reduced glutathione (GSH) modulates the sensitivity of human
melanoma
cells to alkylating drugs in vitro. To investigate whether the membrane-associated enzyme
gamma-glutamyl transpeptidase
(
gamma-GTP
) involved in GSH breakdown was expressed in
melanoma
cells, the enzymatic activity of
gamma-GTP
as well as the secretion of GSH were measured in human
melanoma
cells from four different cell lines (Me8, JUSO, GLL19, Swift). All the cells showed low
gamma-GTP
activities (0-1 mU/mg protein) and released GSH in culture supernatants at significant rates. After incubation for 24 h in growth medium containing 0.1 mmol/L cystine, the levels of GSH in supernatants ranged from 56 to 111 nmol GSH/mg protein. The GSH metabolism of
melanoma
cells was also evaluated by measuring the levels of the melanogenesis intermediate 5-S-cysteinyldopa under different experimental conditions. The results of these experiments suggest that
melanoma
cells have a low ability to metabolize the tripeptide GSH, which appears to be responsible for GSH secretion and accumulation in culture supernatants.
...
PMID:Glutathione efflux associated with a low gamma-glutamyl transpeptidase activity in human melanoma cells. 941 31
There has been a discrepancy between promising results of experimental chemotherapy in animal
melanoma
models and clinical response rates. This inconsistency seems to reflect weak points of the assays used so far to monitor the response of
melanoma
cells to chemotherapeutic agents. Therefore a less usual approach was chosen in the present study: Tumor cells were cultured in peritoneal cavity (B16
melanoma
in inbred C57BL/6J mice and Cloudman S91
melanoma
in inbred DBA2 mice) to maintain normal in vivo conditions; the animals were receiving the tested agents in i.p. injections and the prolongation of their life span was considered as the principle parameter of therapeutic efficiency of the compounds tested. Previously described therapeutic potency both of vitamins (C, alpha-tocopherol acid succinate) and some phenols (hydroquinone, 4-hydroxyanisole) was confirmed. Benzoate, spin trap N-butyl-alpha-phenyl-nitrone and ammonium chloride as a lysosomotropic agent failed to increase the survival of
melanoma
-bearing mice. Free radical scavenger methimazole exerted a therapeutic effect in mice with pigmented B16
melanoma
. Only classic cytostatic agents--cisplatin and cyclophosphamide--proved its therapeutic effect in both
melanoma
models studied. These results are in accord with the known resistance of human
melanoma
to conventional chemotherapy. Measurement of serum activity of
gamma-glutamyltransferase
was shown to be useful for monitoring therapeutic effect.
...
PMID:Experimental chemotherapy of murine melanomas: is there a discrepancy compared to clinical experience? 947 85
The total serum activity of
gamma-glutamyl transpeptidase
(
GGT
) was shown to increase with the growth of transplantable B16 and S91 melanomas in inbred mice. In an effort to define the source of the
GGT
shed into the bloodstream the physicochemical characteristics of the partially purified
GGT
isoforms from liver, serum and B16
melanoma
were compared. The molecular weights of the serum and
melanoma
isoforms were identical (86 kDa) and differed from that of the liver isoform (69 kDa). In polyacrylamide gel electrophoresis the serum and
melanoma
isoforms had a similar mobility which exceeded that of the liver enzyme. Treatment of the enzyme preparations with neuraminidase removed the differences in the electrophoretic mobility of the three
GGT
isoforms studied. On ion exchange chromatography on a DEAE-Spheron 300 LC column the
melanoma
and serum isoforms had an affinity to the sorbent unlike the liver isoform. Our observations suggest that
melanoma
cells express a sialoform of
GGT
which is responsible for an increase in the total
GGT
serum activity. Biochemical and histochemical analyses did not reveal any increase in liver
GGT
production associated with
melanoma
development. Detection of the
GGT
isoform of tumour origin in sera ranks
GGT
among the specific
melanoma
markers.
Melanoma
Res 1998 Feb
PMID:Tumour tissue is a source of gamma-glutamyl transpeptidase sialoform in the sera of melanoma-bearing mice. 950 75
In this study, we evaluated the effect of several ligands active at the central-type and peripheral-type benzodiazepine receptor (BzR) (clonazepam, diazepam, PK11195 and Ro5-4864) on the growth and differentiation of B16
melanoma
cells. All tested BzR ligands were able to suppress proliferation of the cells at the micromolar range and in a concentration-dependent manner. However, agents selectively active at the peripheral-type BzR (PK11195 and Ro5-4864) exhibited more potent antiproliferative activity. In addition, the BzR ligands were demonstrated to affect the cell cycle by reducing the percent of cells in the S phase and increasing the percent in the G2/M phase. BzR ligands induced cellular phenotypic alterations, which have been previously shown to be associated with
melanoma
cell differentiation. These alterations included: marked morphological changes, enhancement of melanogenesis, lipid accumulation and increase in the activity of gamma
glutamyl transpeptidase
. All BzR ligands induced a marked reduction in the concentration of UTP and most of them did the same in GTP and CTP, while ATP levels were not significantly altered. In summary, BzR ligands (clonazepam, diazepam, PK11195 and Ro5-4864) were found to exert antitumor effects in B16
melanoma
cells. These findings encourage further studies of a possible therapeutic potential of BzR ligands in treatment of
melanoma
.
...
PMID:Antiproliferative and differentiating effects of benzodiazepine receptor ligands on B16 melanoma cells. 977 14
The metabolism of glutathione by membrane-bound &ggr;-
glutamyl transpeptidase
(GGT) has been recently recognized as a basal source of hydrogen peroxide in the extracellular space. Significant levels of GGT activity are expressed by malignant tumours, and in
melanoma
cell lines they were found to correlate with the malignant behaviour. As hydrogen peroxide and other oxidants can affect signal transduction pathways at several levels, the present study was aimed to verify: (i) the occurrence of GGT-dependent production of hydrogen peroxide in
melanoma
cells; (ii) the effects of GGT-dependent prooxidant reactions on known redox-sensitive cellular targets, i.e. protein thiols, the nuclear transcription factor NF-kappa B and p53. Two
melanoma
Me665/2 cell clones, exhibiting traces of (clone 2/21) or high (clone 2/60) GGT activity, were studied. The occurrence of GGT-dependent production of hydrogen peroxide was apparent in 2/60 cells, in which it was accompanied by lower levels of cell surface protein thiols. In 2/60 cells, GGT expression was also associated with higher levels of NF-kappa B activation, as compared to GGT-poor 2/21 cell clone. Indeed, stimulation or inhibition of GGT activity in 2/60 cells resulted in progressive activation or inactivation of NF-kappa B, respectively. An analysis of the p53 gene product indicated lack of protein expression in 2/60 cells, whereas a mutant protein was highly expressed in 2/21 cells. Taken together, these results indicate that the expression of GGT activity can provide
melanoma
cells with an additional source of hydrogen peroxide, and that such prooxidant reactions are capable to modify protein thiols at the cell surface level. In addition, GGT expression results in an up-regulation of the transcription factor NF-kappa B, which could explain the higher metastatic behaviour reported for GGT-rich
melanoma
cells as compared to their GGT-poor counterparts.
...
PMID:Membrane gamma-glutamyl transpeptidase activity of melanoma cells: effects on cellular H(2)O(2) production, cell surface protein thiol oxidation and NF-kappa B activation status. 1089 82
Thiol redox status can affect important functions both intracellularly and extracellularly. The plasma membrane enzyme
gamma-glutamyl transpeptidase
(
GGT
), which plays a crucial role in cellular handling of thiols, is often expressed in malignant tumors, including
melanoma
, although its expression levels may vary widely among different tumors or cells of the same tumor. In an attempt to better understand the functional significance of
GGT
overexpression, we have examined the relationships between intra- and extra-cellular thiol metabolism and
GGT
expression. Intra- and extra-cellular distribution of glutathione and other low mol. wt. thiols and disulfides was investigated in two different Me665/2 human
melanoma
clones that originated from the same metastasis, but exhibiting high (2/60 clone) and low (2/21 clone)
GGT
activity. Intracellular content of glutathione was lower in
GGT
-rich 2/60 cells, in spite of high
GGT
expression. A lower utilization of extracellular cystine was also observed in these cells. In both clones, a direct secretion of cysteine in the extracellular medium was detected, which was independent of
GGT
-mediated catabolism of extracellular glutathione. Substantial amounts of glutathione, GSSG and glutathione-cysteine disulfide were accumulated extracellularly only in the case of
GGT
-poor 2/21 cells, while the same event was apparent in 2/60 cells only after the following inhibition of
GGT
activity. When exposed to the trinuclear platinum compound BBR 3464 or hydrogen peroxide, which are very reactive for sulfur-containing nucleophiles, the 2/60 clone showed higher sensitivity than the 2/21 clone to both agents. These results suggest that the clone-specific balance between transport of sulfur aminoacids and
GGT
activity results in profound differences in the capability of each clone to modify the thiol redox status of the extracellular milieu. The finding may have important implications in tumor cell behavior with particular reference to chemosensitivity, since thiols are recognized factors in modulation of cell sensitivity to platinum-based anticancer drugs.
...
PMID:Extra-cellular thiol metabolism in clones of human metastatic melanoma with different gamma-glutamyl transpeptidase expression: implications for cell response to platinum-based drugs. 1185 48
Metabolism of glutathione by
gamma-glutamyl transpeptidase
(
gamma-GT
) at the level of cell membrane has been shown to generate hydrogen peroxide in many cell types including human melanomas.
gamma-GT
does not appear to be involved in cysteine uptake for pheomelanin production in
melanoma
cells and does not contribute significantly to the pheomelanin synthesized in B16
melanoma
cells. We have therefore examined the possibility of
gamma-GT
mediated production of prooxidant reactions and its effect, if any, on pigmentation using B16
melanoma
cells. Our results indicate that in B16
melanoma
cells,
gamma-GT
activity leads to the production of hydrogen peroxide. We further show that the nuclear levels of the redox sensitive transcription factor NF-kappa B is regulated by H2O2 formed by the action of
gamma-GT
: stimulation and inhibition of
gamma-GT
affect the levels of NF-kappa B. Tumor necrosis factor alpha, a hypopigmenting cytokine, known to activate NF-kappa B also up-regulates the
gamma-GT
messenger RNA and activity. Stimulation of
gamma-GT
generated prooxidant reactions led to a decrease in tyrosinase activity. We therefore propose that prooxidant reactions mediated by
gamma-GT
in turn regulate the levels of tyrosinase in pigment cells. Our findings thus introduce a new aspect in the regulation of pigmentation and ascribe a novel role for
gamma-GT
in pigment cells.
...
PMID:Gamma-glutamyl transpeptidase and its role in melanogenesis: redox reactions and regulation of tyrosinase. 1245 83
<< Previous
1
2
3
4
5
6
7
Next >>